Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink
- PMID: 33156197
- PMCID: PMC8108006
- DOI: 10.1097/AOG.0000000000004166
Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink
Abstract
Objective: To evaluate whether the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccinations in pregnancy are associated with increased risk of stillbirth.
Methods: We performed a case-control study in the Vaccine Safety Datalink that was matched 1:4 on site, month, and year of last menstrual period, comparing the odds of vaccination in pregnancies that ended in stillbirth (defined as fetal loss at or after 20 weeks of gestation) compared with those that ended in live birth from January 1, 2012, to September 30, 2015. We included patients with singleton pregnancies that ended in stillbirth or live birth who had at least one prenatal care visit, pregnancy dating information, and continuous health plan enrollment for the duration of pregnancy. Medical records for all stillbirths were reviewed. We were statistically powered to detect an odds ratio (OR) of 1.37 when evaluating the association between influenza or Tdap vaccination and stillbirth. We also examined stillbirth rates in pregnant patients aged 14-49 years in the Vaccine Safety Datalink between 2007 and 2015.
Results: In our matched analysis of 795 confirmed stillbirths in the case group and 3,180 live births in the control group, there was no significant association between influenza vaccination during pregnancy and stillbirth (343/795 [43.1%] stillbirths in the case group vs 1,407/3,180 [44.3%] live births in the control group, OR 0.94, adjusted OR 0.95, 95% CI 0.79-1.14, P=.54) and no significant association between Tdap vaccination during pregnancy and stillbirth (184/795 [23.1%] stillbirths in the case group vs 746/3,180 [23.5%] live births in the control group, OR 0.97, aOR 0.96, 95% CI 0.76-1.28, P=.91). From 2007 to 2015, the stillbirth rate in the Vaccine Safety Datalink was 5.2 per 1,000 live births and stillbirths.
Conclusion: No association was found between vaccination during pregnancy and the odds of stillbirth. These findings support the safety of ACIP recommendations for vaccination during pregnancy.
Figures
Similar articles
-
Infant Hospitalizations and Mortality After Maternal Vaccination.Pediatrics. 2018 Mar;141(3):e20173310. doi: 10.1542/peds.2017-3310. Epub 2018 Feb 20. Pediatrics. 2018. PMID: 29463582 Free PMC article.
-
Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink.Obstet Gynecol. 2024 Aug 1;144(2):215-222. doi: 10.1097/AOG.0000000000005632. Epub 2024 Jun 6. Obstet Gynecol. 2024. PMID: 38843526 Free PMC article.
-
Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System.Vaccine. 2015 Jun 17;33(27):3110-3. doi: 10.1016/j.vaccine.2015.04.097. Epub 2015 May 11. Vaccine. 2015. PMID: 25976546 Free PMC article.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy.Obstet Gynecol Surv. 2012 Apr;67(4):251-7. doi: 10.1097/OGX.0b013e3182524cee. Obstet Gynecol Surv. 2012. PMID: 22495061 Review.
Cited by
-
Increased Identification of Vaccines for Vaccine Safety Surveillance Through Linkage With the Minnesota Immunization Information Connection as of December 31, 2023.Public Health Rep. 2024 Sep 28:333549241280002. doi: 10.1177/00333549241280002. Online ahead of print. Public Health Rep. 2024. PMID: 39342452 Free PMC article.
-
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.Vaccine X. 2024 Feb 23;18:100464. doi: 10.1016/j.jvacx.2024.100464. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38495929 Free PMC article. Review.
-
Safety of influenza vaccination during pregnancy: a systematic review.BMJ Open. 2023 Sep 6;13(9):e066182. doi: 10.1136/bmjopen-2022-066182. BMJ Open. 2023. PMID: 37673449 Free PMC article.
-
Safety and Clinical Benefits of Adacel® and Adacel®-Polio Vaccination in Pregnancy: A Structured Literature Review.Infect Dis Ther. 2023 Aug;12(8):1955-2003. doi: 10.1007/s40121-023-00847-5. Epub 2023 Sep 1. Infect Dis Ther. 2023. PMID: 37653123 Free PMC article. Review.
-
A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals.Front Public Health. 2022 May 23;10:876966. doi: 10.3389/fpubh.2022.876966. eCollection 2022. Front Public Health. 2022. PMID: 35677772 Free PMC article.
References
-
- Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med 2011;24:402–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
